Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Open accessThe DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Transcriptional reprogramming of proliferative melanoma cells into a phenotypically distinct invasive cell subpopulation is a critical event at the origin of metastatic spreading. Here we generate transcriptome, open chromatin and histone modification maps of melanoma cultures; and integrate this data with existing transcriptome and DNA methylation profiles from tumour biopsies to gain insight into the mechanisms underlying this key reprogramming event. This shows thousands of genomic regulatory regions underlying the proliferative and invasive states, identifying SOX10/MITF and AP-1/TEAD as regulators, respectively. Knockdown of TEADs shows a previously unrecognized role in the invasive gene network and establishes a causative link between these transcription factors, cell invasion and sensitivity to MAPK inhibitors. Using regulatory landscapes and in silico analysis, we show that transcriptional reprogramming underlies the distinct cellular states present in melanoma. Furthermore, it reveals an essential role for the TEADs, linking it to clinically relevant mechanisms such as invasion and resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among the SALL4-HDAC2 targets upregulated upon SALL4 knockdown, we found integrins (ITGB1, ITGA6, ITGA4), N-cadherin (CDH2), TGFBR2, VEGFR-1, PDGFC, LOXL2, MAPK8, and many others which are associated with invasive melanoma phenotypes40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [41]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SALL4-regulated genes showed a significant enrichment and positive correlation with published invasiveness signatures40–42, while they significantly anti-correlated with their corresponding proliferation signatures40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Cited by
Items 301–400 of 529
Malysheva, V., Mendoza-Parra, M. A., Blum, M., Spivakov, M., & Gronemeyer, H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/303842 · Cited by 7
Ott, C. A., Purwin, T. J., Chen, P., Chowdhury, S., Mellor, G. L., Luo, K., Mersky, G. L., Tiago, M., Madden, W. D. B., Varney, S. D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64682-7 · Cited by 8
miRNA-driven cancer cell plasticity, tolerance and therapy resistance: lessons from melanoma
Ortolano, A., Frigerio, R., Ciliberto, G., Fattore, L., & Mancini, R. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02603-y · Cited by 6
Moscona, R., Janssen, S. M., Elchebly, M., Papadakis, A. I., Rubin, E., & Spatz, A. (2023) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13089 · Cited by 6
Functional analysis of recurrent CDC20 promoter variants in human melanoma
Godoy, P. M., Oyedeji, A., Mudd, J. L., Morikis, V. A., Zarov, A. P., Longmore, G. D., Fields, R. C., & Kaufman, C. K. (2023) · Communications Biology · doi:10.1038/s42003-023-05526-2 · Cited by 10
Pudjihartono, M., Golovina, E., Fadason, T., O'Sullivan, J. M., & Schierding, W. S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13599 · Cited by 6
Mitchell, K. A., Vissers, J. H. A., Pojer, J. M., Brooks, E., Hilmi, A. J. S., Papenfuss, A. T., Schröder, J., & Harvey, K. F. (2024) · Current Biology · doi:10.1016/j.cub.2024.07.060 · Cited by 6
Salgado, C., Kwesi‐Maliepaard, E. M., Jochemsen, A. G., Visser, M., Harland, M., van Leeuwen, F., van Doorn, R., & Gruis, N. A. (2019) · Melanoma Research · doi:10.1097/cmr.0000000000000640 · Cited by 6
Feng, T., Golji, J., Li, A., Zhang, X., Ruddy, D. A., Rakiec, D. P., Geyer, F. C., Gu, J., Gao, H., Williams, J. A., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0028 · Cited by 7
Braun, A. D., Mengoni, M., Bonifatius, S., Tüting, T., & Gaffal, E. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.12.020 · Cited by 6
MITF Is Regulated by Redox Signals Controlled by the Selenoprotein Thioredoxin Reductase 1
Kline, C. D., Anderson, M., Bassett, J. W., Kent, G., Berryman, R., Honeggar, M., Ito, S., Wakamatsu, K., Indra, A. K., Moos, P. J., et al. (2022) · Cancers · doi:10.3390/cancers14205011 · Cited by 7
Mendelson, K., Martin, T. C., Nguyen, C. B., Hsu, M., Xu, J., Lang, C. C. V., Dummer, R., Saenger, Y. M., Messina, J. L., Sondak, V. K., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.166611 · Cited by 7
Pudjihartono, M., Pudjihartono, N., O'Sullivan, J. M., & Schierding, W. S. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02870-w · Cited by 5
Tracking of Melanoma Cell Plasticity by Transcriptional Reporters
Vidal, A., & Redmer, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031199 · Cited by 8
Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments
Taglialatela, I., Indini, A., Santanelli, G., Liberti, G. D., Guardo, L. D., de Braud, F., & Vecchio, M. D. (2024) · Tumori Journal · doi:10.1177/03008916241231687 · Cited by 5
Translation rewiring at the heart of phenotype switching in melanoma
Leucci, E., Close, P., & Marine, J. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12583 · Cited by 5
Self-citationJiang, Z., Cinti, C., Taranta, M., Mattioli, E., Schena, E., Singh, S., Khurana, R., Lattanzi, G., Tsinoremas, N. F., & Capobianco, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206686 · Cited by 5
Alver, T. N., Heintz, K., Hovig, E. J., & Bøe, S. L. (2022) · Cancer Reports · doi:10.1002/cnr2.1736 · Cited by 6
Cinque, S., Verheyden, Y., Adnane, S., Marino, A., Katopodi, V., Demesmaeker, E., Knezevic, Z., Hanache, S., Vendramin, R., Cuomo, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.06.523012 · Cited by 5
Balderson, B., Fane, M. E., Harvey, T. J., Piper, M., Smith, A. G., & Bodén, M. (2024) · Briefings in Functional Genomics · doi:10.1093/bfgp/elad055 · Cited by 4
Zhu, E. Y., Schillo, J. L., Murray, S., Riordan, J. D., & Dupuy, A. J. (2023) · iScience · doi:10.1016/j.isci.2023.107805 · Cited by 4
Therapeutic Strategies for Drug-resistant Melanoma and Their Clinical Implications
Huang, K., & Kim, M.-O. (2025) · Journal of Cancer Prevention · doi:10.15430/jcp.24.028 · Cited by 6
Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening
Petroulia, S., Hockemeyer, K., Tiwari, S., Berico, P., Shamloo, S., Banijamali, S. E., de Miera, E. V., Gong, Y., Thandapani, P., Wang, E., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0416 · Cited by 4
Singh, K., Baird, M. A., Fischer, R. S., Chaitankar, V., Seifuddin, F., Chen, Y.-C., Tunc, I., Waterman, C. M., & Pirooznia, M. (2020) · Cancers · doi:10.3390/cancers12020458 · Cited by 5
Inactivation of the Hippo Tumor Suppressor Pathway Promotes MelanomaPreprint
Vittoria, M. A., Kingston, N. M., Xia, E., Hong, R., Huang, L., McDonald, S., Tilston-Lünel, A., Darp, R., Campbell, J. D., Lang, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.04.442615 · Cited by 4
Lecacheur, M., Berestjuk, I., Carminati, A., Rabbaa, M., Bouvet, O., Diazzi, S., Biber, P., Rovera, C., Irondelle, M., Larbret, F., et al. (2026) · Oncogenesis · doi:10.1038/s41389-026-00636-y · Cited by 4
Caksa, S., Purwin, T. J., Erkes, D. A., DeRosa, K. M., Kitterman, E. L., Barnada, S. M., Stefanski, C. D., Wilson, H. P., Mersky, G. L., Glasheen, M. Q., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3267 · Cited by 3
Regulatory Mechanisms of SPARC Overexpression in Melanoma Progression
Vinyals, A., Ferreres, J. R., Campos-Martín, R., Jorge-Torres, O. C., Mainez, J., Puig‐Butillé, J. A., Marcoval, J., Puig, S., Fabregat, I., & Fabra, À. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178743 · Cited by 3
Interaction of lncRNA LENT with DHX36 regulates translation and suppresses autophagy in melanoma
Haller, A. R., Gambi, G., D’Agostino, M., Davidson, G., Lallement, A., Mengus, G., Nahy, C., Messaddeq, N., Bec, G., Simonetti, A., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08296-3 · Cited by 5
The Emerging Epigenetic Landscape in Melanoma
Rollins, R. A., Kim, K. H., & Tsao, C. (2016) · InTech eBooks · doi:10.5772/64733 · Cited by 3
Genetic dependencies associated with transcription factor activities in human cancer cell lines
Thatikonda, V., Supper, V., Wachter, J., Kaya, O., Kombara, A., Bilgilier, C., Ravichandran, M. C., Lipp, J., Sharma, R., Badertscher, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114175 · Cited by 3
Čermák, V., Škarková, A., Merta, L., Kolomazníková, V., Palušová, V., Uldrijan, S., Rösel, D., & Brábek, J. (2021) · Biomolecules · doi:10.3390/biom11030449 · Cited by 3
Atak, Z. K., Taskiran, I. I., Flerin, C., Mauduit, D., Minnoye, L., Hulsemans, G., Christiaens, V., Ghanem, G.-E., Wouters, J., & Aerts, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.21.885806 · Cited by 3
Self-citationZhang, Y., Riedstra, C. P., Wang, S., Patel, S. A., Bald, T., Kumar, P., Rohani, A., Kashatus, D. F., Moschos, S. J., & Dudley, A. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.15.500231 · Cited by 3
Binet, R., Lambert, J., Tomková, M., Tischfield, S., Baggiolini, A., Picaud, S., Sarkar, S., Louphrasitthiphol, P., Dias, D., Carreira, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.21.537819 · Cited by 3
Lineage-Specific Transcription Factors in Carcinogenesis
David, C. J., & Vanharanta, S. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060524-105603 · Cited by 3
Loss of fatty acid-binding protein 7 promotes B16F10 melanoma metastasis
Wannakul, T., Miyazaki, H., Maekawa, M., Kagawa, Y., Yamamoto, Y., & Owada, Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-80874-5 · Cited by 3
The rise of new targets in melanoma
Bai, X. L., & Flaherty, K. T. (2025) · British Journal of Dermatology · doi:10.1093/bjd/ljaf251 · Cited by 2
Zeng, J., Lin, L., Ma, Y., Huang, W., Luo, Q., & Wen, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336502 · Cited by 2
Sun, Y., Li, L. Z., Yang, H., Wang, Z., Liu, H., Zhu, Y., Ying, L., Yan, W., Zhang, G., Yang, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-28087-2 · Cited by 2
A Targetable Developmental Program Coregulates Angiogenesis and Immune Evasion in Melanoma
Berico, P., Yanke, A. F., Vand-Rajabpour, F., Do, C., Wilmer, I. S., Delclaux, I., Muijlwijk, T., Stagnitta, R., Vázquez‐Cruz, M. E., Sakellaropoulos, T., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1853 · Cited by 3
Régulation épigénétique de l’expression génique dans le mélanome malin
Laurette, P., Koludrović, D., Coassolo, S., & Davidson, I. (2016) · Biologie Aujourd hui · doi:10.1051/jbio/2016028 · Cited by 2
Drosophila Cancer Modeling Using the Eye Imaginal Discs
Gangwani, K., Snigdha, K., Atkins, M., Singh, S. R., & Kango‐Singh, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-42246-2_9 · Cited by 2
Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis
Pearson, J. D., Huang, K., Pena, L. G. D., Ducarouge, B., Mehlen, P., & Bremner, R. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0101 · Cited by 2
Ho, Y.-J., Anaparthy, N., Molik, D. C., Aicher, T. P., Patel, A. K., Hicks, J. B., & Hammell, M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/239319 · Cited by 2
Sumabat, T. M., Worley, M. I., Pellock, B. J., Bosch, J. A., & Hariharan, I. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/772533 · Cited by 2
Lattmann, E., Jovic, A., Kim, J. J., Pham, T., Corona, C., Lian, Z., Saini, K., Ray, M., Lu, V., Tastanova, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.28.601235 · Cited by 2
Belova, T., Hsieh, P., Hovan, L., Osorio, D., & Kuijjer, M. L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680219 · Cited by 2
Solé-Blanch, C., España, S., de la Puente-Noël, A., Marín-Béjar, O., Manzano, J. L., & Martínez‐Cardús, A. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189503 · Cited by 1
Gap Junction–Mediated Communication in Melanoma: From Tumor Progression to Treatment Response
Massoud, J., Ibrahim, S., Jensen, M., Beary, M. C., Nafchi, B., Springer, M., & Zucker, S. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062705 · Cited by 1
Sævarsson, T., de Lomana, A. L. G., Sánchez, Ó., Brynjolfsson, S. F., Steingrímsson, E., & Einarsdottir, B. O. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02840-0 · Cited by 1
Shah, K., Nguyen, D. A. H., Gold, M. P., Villacampa, E. G., Galicia, L. A., HUANG, H. H., Chen, X. M., Sun, J., Guo, Y., Gaddam, S., et al. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-25-02766 · Cited by 1
Computational Analysis of Epigenetic Modifications in Melanoma
Tang, M., & Rai, K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814513-5.00020-9 · Cited by 2
Yun, J., Jin, X., Sun, Q., Xu, L., Gao, J. Y., Wang, X., & Zhao, S. (2022) · Bioelectromagnetics · doi:10.1002/bem.22412 · Cited by 1
Bejjani, F., Evanno, E., Mahfoud, S., Tolza, C., Zibara, K., Piechaczyk, M., & Jariel‐Encontre, I. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01077-5 · Cited by 3
Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Shinada, M., Kato, D., Motegi, T., Tsuboi, M., Ikeda, N., Aoki, S., Iguchi, T., Li, T., Kodera, Y., Ota, R., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0929 · Cited by 1
Parab, S., Sarlo, V., Capellero, S., Palmiotto, L., Bartolini, A., Cantarella, D., Turi, M., Gullà, A., Grassi, E., Lazzari, C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011228 · Cited by 2
TFIIH kinase CDK7 antagonizes phenotype switching and emergence of drug tolerance in melanomaPreprint
Berico, P., Cigrang, M., Braun, C., Davidson, G., Sandoz, J., Gras, S. L., Peyresaubes, F., Robles, C. M. G., Egly, J., Compe, E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.24.311431 · Cited by 2
Centore, R. C., Soares, L. M. M., Topal, S., Vaswani, R. G., Ichikawa, K., Li, Z., Fan, H. B., Setser, J. W., Lahr, D. L., Zawadzke, L. E., et al. (2024) · eLife · doi:10.7554/elife.93478 · Cited by 2
Centore, R. C., Soares, L. M. M., Topal, S., Vaswani, R. G., Ichikawa, K., Li, Z., Fan, H. B., Setser, J. W., Lahr, D. L., Zawadzke, L. E., et al. (2024) · eLife · doi:10.7554/elife.93478.1 · Cited by 2
Tchara, P.-E. K., Loehr, J., Germain, L., Steinhart, Z., Gonzalez-Badillo, B., Lashgari, A., Chartier, F. J.-M., Tucholska, M., Picaud, S., Knight, J. D. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.22.604604 · Cited by 2
Centore, R. C., Soares, L. M. M., Topal, S., Vaswani, R. G., Ichikawa, K., Li, Z., Fan, H. B., Setser, J. W., Lahr, D. L., Zawadzke, L. E., et al. (2025) · eLife · doi:10.7554/elife.93478.3 · Cited by 1
Impact of texturing on sliding wear behaviour of UHMWPE
Eddoumy, F. (2012) · theses.fr (ABES) · doi:10.70675/8db88ecczf223z441bz8f27z896478d1faf3 · Cited by 1
stringgaussnet: from differentially expressed genes to semantic and Gaussian networks generation
Chaplais, E., & Garchon, H. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv450
Maretty, L., Sibbesen, J. A., & Krogh, A. (2014)
Une approche de modélisation de biologie des systèmes sur la spondylarthrite
Chaplais, E. (2015) · theses.fr (ABES) · doi:10.70675/eb753ddeze85dz473dzb50czcf88d00862e7 · Cited by 1
Escaping BRAF inhibition: A “linc” with non‐coding RNA s?
Leucci, E. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12655
Transcription factor AP2 paralogs in melanocytes and melanoma
Seberg, H., Rutkowski, D. T., Cornell, R. A., Bassuk, A. G., Dupuy, A. J., & Tootle, T. L. (2018) · doi:10.17077/etd.sqn0ydsj
Meierjohann, S., & Schilling, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811785-9.00046-6
Genomic Applications in Melanoma
Granada, C. N. P., Arnam, J. V., Shah, K., Andea, A. A., & Lazar, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-96830-8_34
The control of melanoma by the Hippo pathway
Yang, L. (2018) · Minerva Access (University of Melbourne)
Effern, M. (2019) · bonndoc (University of Bonn)
Wong, T. C. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Rôle de MITF et du métabolisme des sphingolipides dans le mélanome cutané
Leclerc, J. (2019) · theses.fr (ABES) · doi:10.70675/e6ceb3b4z96a2z4196za809z97cd83844103
Structure, Function, and Inhibition of the Oncogenic RhoGEF Trio
Bandekar, S. J. (2020) · Deep Blue (University of Michigan)
Flatz, L., Ring, S. S., Pop, O. T., Poźniak, J., Berner, F., Ali, O. H., Abdou, M.-T., Diem, S., Bomze, D., Niederer, R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-403313/v1
Self-citationSiena, Á. D. D. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-04102021-152128
Author response: Analysis of long and short enhancers in melanoma cell states
Mauduit, D., Taskiran, I. I., Minnoye, L., Waegeneer, M. D., Christiaens, V., Hulselmans, G. J., Demeulemeester, J., Wouters, J., & Aerts, S. (2021) · eLife · doi:10.7554/elife.71735.sa2
Self-citationTranscriptional Regulation in Melanoma
Yokoyama, S., & Fisher, D. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_5
A Systems Approach to Overcome Tumor-cell Heterogeneity in Drug Response: Metrics and Mechanisms
Comandante-Lou, N. (2022) · Deep Blue (University of Michigan) · doi:10.7302/5949
The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanomaPreprint
Raymond, J. H., Pouteaux, M., Petit, V., Aktary, Z., Luciani, F., Wehbe, M., Gizzi, P., Bourban, C., Martianov, I., Davidson, I., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.02.518844
Self-citationKramer, E. T., Godoy, P. M., & Kaufman, C. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.05.519210
Rovera, C., Berestjuk, I., Lecacheur, M., Tavernier, C., Diazzi, S., Pisano, S., Irondelle, M., Mallavialle, A., Albrengues, J., Gaggioli, C., et al. (2023) · doi:10.1158/0008-5472.c.6513435.v1
Applications of bioinformatics and machine learning in the analysis of proteomics data
Li, B. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1818
Cooperativity in melanoma metastasis
Ng, M. F. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.242136
Popovic, A. (2021) · theses.fr (ABES) · doi:10.70675/7d530d71zf67az40a6z8295z2fa586dd1079 · Cited by 3
Carrié, L. (2023) · theses.fr (ABES) · doi:10.70675/eecd40a7z9c50z4d29z83b3z8659e4f94eb8 · Cited by 1
Davidson, G. (2023) · theses.fr (ABES) · doi:10.70675/2fd472a2zeb06z4d65z8addz94d5f5471e64 · Cited by 1
Targeting lncRNAs in human cancer : insights into melanoma and clear cell renal cell carcinoma
Gambi, G. (2021) · theses.fr (ABES) · doi:10.70675/7af0fc37z1d72z4785za771z630db8483a71
Targeting transcriptional addiction in cutaneous melanoma
Cigrang, M. (2023) · theses.fr (ABES) · doi:10.70675/32a61798z3cd7z4cd8za2acza750367acaf5
The role of YAP oncogene in the control of mitochondrial function
Wei, C. (2021) · theses.fr (ABES) · doi:10.70675/205ff903ze3b3z42e8z81eaz198b97b47523
He, D., Xin, T., Pang, B., Sun, J., Liu, Z., Qin, Z., Ji, X. S., Yang, F., Wei, Y. B., Wang, Z. X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612190
He, D., Xin, T., Pang, B., Sun, J., Liu, Z., Qin, Z., Ji, X. S., Yang, F., Wei, Y. B., Wang, Z. X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612205
He, D., Xin, T., Pang, B., Sun, J., Liu, Z., Qin, Z., Ji, X. S., Yang, F., Wei, Y. B., Wang, Z. X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612202
He, D., Xin, T., Pang, B., Sun, J., Liu, Z., Qin, Z., Ji, X. S., Yang, F., Wei, Y. B., Wang, Z. X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612199
Halstead, M. M., Kern, C., Saelao, P., Wang, Y., Chanthavixay, G., Medrano, J. F. F., Eenennaam, A. L. V., Korf, I. F., Tuggle, C. K., Ernst, C. W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13065665
Halstead, M. M., Kern, C., Saelao, P., Wang, Y., Chanthavixay, G., Medrano, J. F. F., Eenennaam, A. L. V., Korf, I. F., Tuggle, C. K., Ernst, C. W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13065653
He, D., Xin, T., Pang, B., Sun, J., Liu, Z., Qin, Z., Ji, X. S., Yang, F., Wei, Y. B., Wang, Z. X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612196
He, D., Xin, T., Pang, B., Sun, J., Liu, Z., Qin, Z., Ji, X. S., Yang, F., Wei, Y. B., Wang, Z. X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612184
Metadata
- Authors
- Verfaillie, A., Imrichova, H., Atak, Z. K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., Luciani, F., Van den Mooter, L., Claerhout, S., Fiers, M., Journe, F., Ghanem, G.-E., Herrmann, C., Halder, G., Marine, J.-C., & Aerts, S.
- Affiliations
- KU Leuven (BE)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Université Libre de Bruxelles (BE)
- German Cancer Research Center (DE)
- Corresponding author
- Aerts, Stein
- ORCID
- Venue
- Nature Communications
- Published
- 2015-04-09
- Volume
- 6
- Issue
- 1
- Pages
- 6683-6683
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4403341
- OpenAlex
- W2018433132
- Cited by
- 489
- References
- 72
- Citations by year
- 2026: 27 · 2025: 32 · 2024: 59 · 2023: 56 · 2022: 59 · 2021: 50 · 2020: 56 · 2019: 41 · 2018: 33 · 2017: 39 · 2016: 24 · 2015: 11
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- Funders
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
- Kom op tegen Kanker
- Fondation contre le Cancer
- Stand Up To Cancer
- Bijzonder Onderzoeksfonds UGent
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- melanoma, cell invasion, transcriptional reprogramming, TEAD transcription factors, SOX10, MITF, AP-1, MAPK inhibitors, MAPK inhibitor resistance, chromatin accessibility, histone modifications, DNA methylation, metastasis
- MeSH terms
- TEA Domain Transcription Factors, Antineoplastic Agents, Cell Transformation, Neoplastic, Chromatin, DNA-Binding Proteins, Histones, Humans, Melanoma, Neoplasm Invasiveness, Nuclear Proteins, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Expression Regulation, Neoplastic, Transcription Factor AP-1, DNA Methylation, Protein Isoforms, RNA, Small Interfering, Cell Line, Tumor, Protein Kinase Inhibitors, Microphthalmia-Associated Transcription Factor, Gene Regulatory Networks, SOXE Transcription Factors, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.